Biocon Limited Declares No Share Encumbrance by Promoters for FY 2025-26
Biocon Limited declared no share encumbrance by promoters and promoter group entities for FY 2025-26, submitting the formal declaration on April 02, 2026. The company confirmed compliance with SEBI Regulation 31(4) regarding substantial acquisition of shares and takeovers, with Company Secretary Rajesh Umakant Shanoy signing the declaration covering the period ending March 31, 2026.
*this image is generated using AI for illustrative purposes only.
Biocon Limited has formally declared that its promoters and promoter group entities maintained no encumbrance on shares throughout the financial year 2025-26. The biotechnology company submitted this declaration on April 02, 2026, in compliance with regulatory requirements under SEBI's takeover regulations.
Regulatory Compliance Declaration
The declaration was made pursuant to Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Syngene International received formal notification along with both major stock exchanges regarding this compliance matter.
| Parameter: | Details |
|---|---|
| Declaration Date: | April 02, 2026 |
| Financial Year Covered: | 2025-26 |
| Year-end Date: | March 31, 2026 |
| Signatory: | Rajesh Umakant Shanoy |
| Designation: | Company Secretary and Compliance Officer |
Share Encumbrance Status
The company confirmed that none of the entities belonging to the promoter and promoter group category, along with persons acting in concert, created any encumbrance on shares held directly or indirectly in the company. This declaration covers the entire duration of the financial year 2025-26 and the position as of March 31, 2026.
Corporate Communication
Company Secretary and Compliance Officer Rajesh Umakant Shanoy, membership number ACS 16328, digitally signed the declaration from Bengaluru. The formal communication was addressed to multiple parties including the Audit Committee Chairperson, BSE Limited's Department of Corporate Services, and the National Stock Exchange of India Limited's Corporate Communication Department.
This declaration represents standard regulatory compliance for listed companies, ensuring transparency in promoter shareholding patterns and maintaining investor confidence through proper disclosure of any potential encumbrances on promoter holdings.
Historical Stock Returns for Syngene International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.67% | -3.11% | +5.87% | -36.30% | -43.78% | -29.78% |
Will Biocon's promoters consider pledging shares for future expansion financing or strategic acquisitions?
How might this clean shareholding structure position Biocon for potential partnerships with global pharmaceutical companies?
Could Biocon's unencumbered promoter holdings make it a more attractive target for institutional investors or merger activities?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
